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The clinical efﬁcacy (reduction of symptoms, global assessment
by patient and physician) was similar between the two treatment
groups.
Conclusion: The IPD meta-analysis using objective parameters
(eliminationof bacteriuria) demonstrated equivalent efﬁcacy (non-
inferiority) of nitroxoline with the controls tested (cotrimoxazole,
norﬂoxacin) in the treatment of uUTI.With a ﬁve (sporadic uUTI) or
ten day (recurrent uUTI) therapy elimination of bacteriuria can be
achieved in over 90% of the patients. Considering the good safety
andefﬁcacyofnitroxoline and theworldwide increaseof resistance
of uropathogens against cotrimoxazole and ﬂuoroquinolones, but
not against nitroxoline within the last 20 years, nitroxoline should
be reconsidered as one of the ﬁrst line antibiotics for the treatment
of uUTI.
http://dx.doi.org/10.1016/j.ijid.2014.03.840
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Background: Tuberculosis (TB) is a major cause of morbidity
andmortalityworldwide. Co-infectionwithHIVand theemergence
of drug-resistant Mycobacterium tuberculosis strains (MDR-and
XDR-TB) has reafﬁrmed TB as a global public health threat. New
therapies are urgently needed. An alternative approach to gen-
erate new TB treatment options in a timely and cost-effective
manner is “repurposing” clinically used drugs with known phar-
maceutical properties. In the course of a screening program [PMID:
21576426], we identiﬁed the in vitro anti-tuberculosis activity of
the anthelmintic avermectins (ivermectin, selamectin, moxidectin
and doramectin) [PMID: 23165468].
Methods & Materials: We performed a literature search on the
pharmacological properties of the avermectins. We integrated this
informationwith our in vitrodata and calculated a theoretical phar-
macodynamic value (AUC/MIC; a measure of drug exposure) to
deﬁne potential in vivo efﬁcacy. We validated our analysis by eval-
uating avermectins in an in vivo model of M. tuberculosis infection.
Results: An AUC/MIC ratio of 10 to 15 was calculated for
bactericidal activity of the avermectins. Due to tolerability and
pharmacokinetic issues the low maximal plasma concentrations
of ivermectin (ng/mL range) resulted in a low calculated exposure
(AUC/MIC < 1). Moxidectin had a longer half-life than ivermectin
and, therefore, the calculated AUC/MIC ratios increased. However,
this was still not enough to provide theoretical in vivo activity. In
contrast, selamectin’s pharmacokinetic properties suggest that it
might be effective in vivo against M. tuberculosis; high plasma con-
centrations (g/mL range), low toxicity (LD50 >1,600mg/kg bw),
and theoretical AUC/MIC ratios are consistentwith potential in vivo
activity. Interestingly, reported concentrations of selamectin in the
lungs (the main site where M. tuberculosis resides) were ca. 2-fold
higher than in plasma, suggesting even higher AUC/MIC ratios at
the site of infection.We therefore tested ivermectin and selamectin
for in vivo activity against M. tuberculosis. Our predictions were
consistent with the in vivo data; while ivermectin at the highest
possible safe dose did not have anti-mycobacterial activity in vivo,
selamectin was active.
Conclusion: This theoretical data analysis supports the poten-
tial of selamectin for TB therapy, including MDR- and XDR-TB, and
warrant further in vivo testing in mouse infection models.
http://dx.doi.org/10.1016/j.ijid.2014.03.841
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Background: Emphysematous osteomyelitis is a rare but ful-
minant disease. Therefore, radiologists should be aware of the
implication of intraosseous gas signs for quick diagnosis.
Methods & Materials: Case: A 55-year-old woman with dia-
betes mellitus and hypertension was admitted to the emergency
department and presented with high fever (40 ◦C), nausea, and
pelvic pain. Physical examination revealed pelvic and pubic ten-
derness on deep palpation. Laboratory data included leukocytosis
(12390/mm3 with 85.5% neutrophilis), high procalcitonin (33.8
ng/ml), C-reactiveprotein (211mg/dl) levels, a high sedimentation
rate (80mm/h), also elevated blood sugar (290mg/dl), and elevated
hemoglobin A1C level (13.4%). Blood cultures were obtained prior
to the initiation of antimicrobial therapy.
Abdominal ultrasonographic examination revealed cholelithi-
asis without gallbladder wall thickening and a small amount of
isolated pelvic free ﬂuid. A subsequent CT of her abdomen and
pelvis showed multiple gas bubbles in the medullary cavity of the
bilateral pubic bones, extending into the anterior acetabulum. A
moderate amount of gas was seen in the soft tissues surrounding
the pubis. Also, marked subcutaneous reticulation and low attenu-
ation areas of subcutaneous gas were detected in the right gluteal
region. MRI conﬁrmed the CT ﬁndings and provided clearer images
of the small abscess formations and the peripubic soft tissue com-
ponent of the infection. CT-guided biopsy of prepubic soft tissue
collection was performed, and Escherichia coli was cultured from
the diagnostic specimen.
Results: Intravenosus (IV) imipenemcilastatin (4×500mg) and
vancomycin (2×1g) was started as an empirical treatment. The
patient underwent urgent surgical debridement of the soft tissue
abscess. All samples (biopsy–surgical specimens and blood cul-
tures) revealed a monomicrobial growth of E. coli. Intravenosus
ciproﬂoxacin (2×400mg) was started based on the antibiogram
results. The ﬁrst 3 weeks of treatment was completed as IV ther-
apy. The patient was discharged with oral antibiotic treatment
(ciproﬂoxacin 2×750mg). The patient’s treatment was completed
in 6 weeks. No complications were seen and she continues to be
followed up.
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Conclusion: In conclusion, we want to emphasize two points.
First, emphysematous osteomyelitis is a rare but fulminant disease.
Second, infections in diabetic subjects will be more serious than in
non-diabetic patients.
http://dx.doi.org/10.1016/j.ijid.2014.03.842
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Background: Here, we presented a tetanus case treated with
botulinum toxin, which is reported in a small number of cases in
the literature.
Methods & Materials: A 73-year-old male patient had a punc-
ture wound to the sole of his left foot caused by a wood splinter 10
days earlier. Patient received tetanus shot the same day but did not
have wound care or immunoglobulin administration. On day 7 of
the injury, the patient sought medical attention from a number of
medical care facilities for trismus and presented to our Outpatient
Clinic on day 10. Physical examination showed trismus, risus sar-
donicus and a wound with necrotic crust on the sole of the left foot
measuring 1x1 cm. Laboratory ﬁndingswere unremarkable besides
elevated creatinin phosphokinase of 967 U/L (N: 30-200 U/L). The
patient was admitted with tentative diagnosis of tetanus.
Results: Surgical drainage and debridement was carried out
and tetanus toxoid and tetanus immunoglobulin was adminis-
tered. Patient was placed on intravenous metronidazol 500mg QID
empirically. The patient was transferred to Anesthesiology and
Reanimation Unit when contractions started 6hours after being
admitted. Sedation was achieved by Phentanyl and Dormicum.
Upon development of severe contractions and signs of autonomic
dysfunction, sedation was increased and the patient was placed
on mechanical ventilator. Sedation was reduced intermittently but
could not be discontinued due to ongoing contractions. Patient did
not experience an alleviation in contractions even after a week
of treatment and on day 8 of admittance, a total of 300 units of
botulinum toxin was administered bilaterally into the masetter,
trapezius, quadriceps and rectus abdominis muscles. By this, we
aimed to prevent the complications of tetanus, especially respira-
tory failure. Following theadministration, reduction incontractions
were observed and the patient is currently under follow-up.
Conclusion: Tetanus is a serious infectious diseases character-
ized by complications secondary to contractions. Botulinum toxin
is a new therapeutic modality tried in a limited number of cases to
prevent many complications including respiratory failure.
http://dx.doi.org/10.1016/j.ijid.2014.03.843
Type: Poster Presentation
Final Abstract Number: 49.011
Session: Antibiotics I
Date: Thursday, April 3, 2014
Time: 12:45-14:15
Room: Ballroom
Evaluation of urinary infections in elderly
patients
S. Ozcimen1,∗, M. Ozcan2, H. Karatas2, A. Sakiz2,
F. Kacar2, F. Korkmaz2, L.S. Demir3
1 Konya state hospital, Konya, Turkey
2 Konya training and research hospital, Konya,
Turkey
3 Konya Public Health, Konya, Turkey
Background: The impairment in function of the cellular and
humoral immune cells and deterioration in physiological defense
mechanism in elderlymakes themprone to infectious diseases. The
urinary tract infections in elderly constitute 25% of the community-
acquired bacterial infections.
Methods & Materials: The records of patients over 65 years-
old diagnosed as urinary tract infection (UTI) according to Centers
for Disease Control and Prevention criteria were retrospectively
evaluated.
Results: Fifty-six patients diagnosed as UTI were included in
the study. Of the 56 patients recruited, 27 were male (48.2%)
and 29 were female (51.8%) and the mean age of the females
was 75.5±7.1 years, and the mean age of males was 76.8±7.5. Of
the total number of UTI, 75% were community-acquired and 25%
were nosocomial. The urine cultures of the female patients yielded
ExtendedSpectrumBeta Lactamase (ESBL) positive E. coli in 7 cases,
ESBL negative E. coli in 9 cases, pseudomonas aeruginosa in 1 case
andno pathogen in 12 cases. The urine cultures of themale patients
yielded ESBL positive E. coli in 8 cases, ESBL negative E. coli in 4
cases, ESBL positive Klebsiella pneumonia in 3 cases, pseudomonas
aeruginosa in1case, Enterococcusaviumin1case,Meticilline resis-
tant coagulase negative staﬁlococcus in 1 case and no pathogen 9
cases. Culture was negative in patients who has received antimi-
crobial treatment before. The UTI was treated in 51 patients.
Conclusion: Bacteriuria is frequent in geriatric population. The
most encountered pathogen was E. Coli in this age group. There
are many risk factors predisposing to infections in elderly patients:
deterioration in immune functions, diabetes mellitus, prostatism
and long hospitalization. The most signiﬁcant predisposing factor
was diabetes mellitus in elderly patients diagnosed as UTI.
http://dx.doi.org/10.1016/j.ijid.2014.03.844
